Combined panel of serum human tissue kallikreins and CA-125 for the detection of epithelial ovarian cancer-Reference-Cited by-同舟云学术

Combined panel of serum human tissue kallikreins and CA-125 for the detection of epithelial ovarian cancer

Published:2012 Issue:3 Volume:23 Page:175
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Koh Stephen Chee Liang¹,Huak Chan Yiong²,Lutan Delfi³,Marpuang Johny³,Ketut Suwiyoga⁴,Budiana Nyoma Gede⁴,Saleh Agustria Zainu⁵,Aziz Mohamad Farid⁶,Winarto Hariyono⁶,Pradjatmo Heru⁷,Hoan Nguyen Khac Han⁸,Thanh Pham Viet⁸,Choolani Mahesh¹

Affiliation:

1. Department of Obstetrics and Gynaecology, National University Health System (NUHS), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

2. Biostatistics Unit, National University Health System (NUHS), Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

3. Department of Obstetrics and Gynaecology, Adam Malik Hospital, University of North Sumatera, Medan, Indonesia.

4. Department of Obstetrics & Gynaecology, Sanglah Denpasar Hospital, University of Udayana, Denpasar, Indonesia.

5. Department of Obstetrics & Gynaecology, Dr Mohammad Hoesin General Hospital, Uiiversity of Sriwijaya, Palembang, Indonesia.

6. Department of Obstetrics & Gynaecology, Division of Oncology, University of Indonesia, Jakarta, Indonesia.

7. Department of Obstetrics & Gynaecology, Dr Sardjito Hospital, University Gadja Mada, Yogyakarta, Indonesia.

8. Tu Du Hospital, Ho Chi Minh, Vietnam.

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynaecology,Oncology,General Medicine

Link

https://synapse.koreamed.org/pdf/10.3802/jgo.2012.23.3.175

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment;Frontiers in Drug Delivery;2024-02-01

2. The Role of Natural and Semi-Synthetic Compounds in Ovarian Cancer: Updates on Mechanisms of Action, Current Trends and Perspectives;Molecules;2023-02-22

3. The prognostic and diagnostic potential of kallikrein-related peptidases in ovarian cancer;Expert Review of Molecular Diagnostics;2021-05-14

4. The occurrence of ovarian cancer in the population of urban and rural women, BRCA1 and BRCA2 genes mutation testing and the general rules on the patient’s consent to treatment;Pielegniarstwo XXI wieku / Nursing in the 21st Century;2021-04-06

5. Advanced drug delivery systems in the treatment of ovarian cancer;Advanced Drug Delivery Systems in the Management of Cancer;2021